CCL27 and neoplasm: Again, this single-arm trial is unable to distinguish between the sole effect of COX inhibition to promote CTACK compared to ICI alone, but may point to an important mechanism of cytotoxic T cell recruitment which may further augment the anti-tumor immune response.